NDC 0074-7095 – Qulipta

Atogepant 10 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0074-7095

Product details

Brand name
Qulipta
Generic name
Atogepant
Labeler
AbbVie Inc.
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA215206
Marketed since
September 30, 2021
Listing expires
December 31, 2027
Pharmacologic class
Calcitonin Gene-related Peptide Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Qulipta →

Package NDC codes (1)

Package NDCDescriptionSince
0074-7095-3030 TABLET in 1 BOTTLE (0074-7095-30)Sep 30, 2021

Other Qulipta products